A new DNA origami vaccine platform called DoriVac could overcome key limitations of mRNA vaccines. Early tests show it triggers strong immune responses while being more stable and easier to produce. Credit: Shutterstock The COVID-19 pandemic brought messenger RNA (mRNA) vaccines into the global spotlight. After completing clinical trials, the first COVID-19 mRNA vaccine was given on December 8, 2020. Researchers later estimated through modeling that these vaccines prevented at least 14.4

Tag-uri: DNA Coronavirus